The Food and Drug Administration has granted an emergency use authorization to a drug for treating Covid-19, although there is little evidence so far to demonstrate that it works.
In a letter Saturday to Rick Bright, director of the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority, FDA chief scientist Denise Hinton wrote that the agency had granted Bright’s request for an EUA for oral formulations of hydroxychloroquine sulfate and chloroquine phosphate, two closely related malaria drugs that have been tested as treatments for Covid-19.
Image: A pharmacy employee in Paris holds up a box of chloroquine
